Dear users,
DigiFinex will list Serum(SRM) at 18:00(GMT+8), Mar 15th, 2022. The trading service of SRM/USDT will be opened at 18:00 (GMT+8), Mar 15th, 2022. The specific schedule is as follows:
- Time of opening deposit: Mar 15th, 2022 18:00 (GMT+8)
- Time of opening trading: Mar 15th, 2022 18:00 (GMT+8)
- Time of opening withdrawal: Mar 17th, 2022 18:00 (GMT+8)
- Trading pair: SRM/USDT
Project name: Serum(SRM)
Official website: https://www.projectserum.com/
Block explorer: https://solscan.io/token/SRMuApVNdxXokk5GT7XD5cUUgXMBCoAz2LHeuAoKWRt
Serum is a decentralized exchange (DEX) and ecosystem that brings unprecedented speed and low transaction costs to decentralized finance (DeFi). (DeFi).
Serum is the only high-performant DEX designed around a fully on-chain central limit order book and matching engine. Ecosystem partners can compose with Serum’s on-chain orderbook to share liquidity and power their trading features for institutional and retail users.
Risk Alert: This is a new token project that poses higher risks than others, which will face potential high price volatility. Please ensure you have done your own research in regards to the fundamental concepts and fully understand this project before opting to trade. DigiFinex will make the best efforts to list high-quality token projects, but will not be responsible for any of your trading losses.
Thank you for your support!
DigiFinex Team
Mar 15th, 2022
DigiFinex communities:
Telegram Official Community: https://t.me/DigiFinexEN
Telegram AMA Community: https://t.me/DigiFinexAMA
Official Facebook: https://www.facebook.com/digifinex.global
Official Twitter: https://twitter.com/digifinex
Official Instagram: https://www.instagram.com/digifinex.global
Official Medium: https://medium.com/@digifinex
Official Reddit: https://www.reddit.com/user/DigiFinex/
Official Kakao: https://open.kakao.com/o/giKpLDsb
DigiFinex (digifinex.com)DIGIFINEX LIMITED. reserves all rights of this event, including but not limited to adjustment, explanation and termination at any time.
Comments
0 comments
Article is closed for comments.